BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3857511)

  • 1. Enoxacin for the treatment of urinary tract infection.
    Bailey RR; Peddie BA
    N Z Med J; 1985 Apr; 98(777):286-8. PubMed ID: 3857511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term treatment and clinical evaluation of enoxacin in complicated urinary tract infections].
    Washida H; Sakagami H; Iwase Y; Sasaki S
    Hinyokika Kiyo; 1987 Sep; 33(9):1508-12. PubMed ID: 3481218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of enoxacin and norfloxacin in patients with cystitis.
    Yamamoto M; Nagai T; Takaba H; Hashimoto J; Miyake K
    Hinyokika Kiyo; 1987 Dec; 33(12):2141-4. PubMed ID: 3482344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical studies on enoxacin in urinary tract infection].
    Nagai N; Kaneko S; Akiyama T; Kurita T; Iguchi M; Kataoka K
    Hinyokika Kiyo; 1988 Jul; 34(7):1283-91. PubMed ID: 3051955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enoxacin: a new fluoroquinolone.
    Jaber LA; Bailey EM; Rybak MJ
    Clin Pharm; 1989 Feb; 8(2):97-107. PubMed ID: 2645085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experience of enoxacin in the treatment of nongonococcal urethritis].
    Nakano E; Ichikawa Y; Ishibashi M; Okuyama A; Matsuda M; Takaha M; Sonoda T; Fujioka H; Matsui T
    Hinyokika Kiyo; 1987 Feb; 33(2):305-9. PubMed ID: 3473920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy of aztreonam in patients with complicated urinary tract infections].
    Yoshida K; Uchijima Y; Kobayashi N; Suwata J; Nakame Y; Saitoh H; Negishi T; Yamada T; Kageyama Y; Kura N
    Hinyokika Kiyo; 1988 Dec; 34(12):2225-32. PubMed ID: 3071130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibacterial therapy of complicated urinary infections in outpatients].
    Rafal'skiÄ­ VV; StrachunskiÄ­ LS; Kogan MI; Petrov SB; Grinev AV; Shevelev AN
    Urologiia; 2004; (5):25-31. PubMed ID: 15560157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enoxacin treatment of urinary tract infections.
    Thomas MG; Ellis-Pegler RB
    J Antimicrob Chemother; 1985 Jun; 15(6):759-63. PubMed ID: 3861605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience of enoxacin complicated urinary tract infection].
    Togashi M; Arakawa M; Tsubo S; Sakashita S; Maru A; Koyanagi T; Nakanishi S; Kakizaki H; Minami S; Kanagawa K
    Hinyokika Kiyo; 1988 Dec; 34(12):2233-6. PubMed ID: 3071131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
    Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of enoxacin and co-trimoxazole in the treatment of patients with complicated urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():113-8. PubMed ID: 3258862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on clinical effects of tosufloxacin (TFLX) and the long-term low dose therapy for the prophylaxis of recurrent urinary tract infection].
    Sakurai M; Sugimura Y; Arima K; Kawamura J; Saitou K; Tajima K; Nakano S; Satani H; Nagano M; Hoshina A
    Hinyokika Kiyo; 1994 Mar; 40(3):279-84. PubMed ID: 8178752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open study of the safety and efficacy of enoxacin in complicated urinary tract infections.
    Foot M; Williams G; Want S; Roe M; Quaghebeur G; Bates S
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():97-103. PubMed ID: 3129393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infectiology of the urogenital tract. 5. Therapy of complicated and nosocomial urinary tract infections and of unusual pathogens--selection of antibiotics].
    Naber KG
    Fortschr Med; 1997 Jun; 115(16):48-50. PubMed ID: 9280749
    [No Abstract]   [Full Text] [Related]  

  • 16. [Uropathogens and antimicrobial susceptibility in outpatients].
    Hunjak B; Pristas I; Stevanović R
    Acta Med Croatica; 2007 Feb; 61(1):111-5. PubMed ID: 17593651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxacin in the treatment of complicated urinary tract infections.
    Roe CJ; Becker GJ; Whitworth JA; Kincaid-Smith P
    Aust N Z J Med; 1987 Feb; 17(1):81-2. PubMed ID: 3304243
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effectiveness of enoxacin for the treatment of complicated urinary tract infection].
    Germinario C; Quarto M; Viggiani N; Schena FP
    Riv Eur Sci Med Farmacol; 1992; 14(5):347-51. PubMed ID: 1308966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous enoxacin for the treatment of acute pyelonephritis: pharmacokinetic and clinical study.
    Bailey RR; Walker RJ; Lynn KL; Donaldson IM; Peddie BA; Dobbs BR
    Br J Clin Pharmacol; 1988 Feb; 25(2):223-8. PubMed ID: 3162809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of modern aminoglycosides in urological practice].
    Derevianko II
    Urologiia; 2004; (6):16-9. PubMed ID: 15719723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.